BioScrip to acquire CarePoint Partners for $223 million

Combined company to serve about 100,000 patients

ELMSFORD, N.Y. — BioScrip will acquire a Cincinnati-based home infusion company for $223 million, BioScrip said Monday.

BioScrip, an Elmsford, N.Y.-based specialty pharmacy provider, said the acquisition of CarePoint Partners Holdings would complement its business, as both companies are providers of home-infusion services. CarePoint Partners is expected to generate about $160 million in annual sales and serves about 20,500 patients each year, with 28 sites in nine states on the East Coast and Gulf Coast regions. Combined, the two companies will serve about 100,000 patients.

"CarePoint Partners is a highly regarded infusion company with a national reputation for clinical excellence, high-quality customer service and superior patient care," BioScrip president and CEO Rick Smith said. "With its strong clinical capabilities, CarePoint Partners has delivered consistent, long-term growth and is now one of the 10 largest home infusion companies."


Login or Register to post a comment.